Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9889)	5/10/1999 10:46:00 PM
From: Edscharp	Read Replies (1) \| Respond to of 17367

MTSL - May 6, 1999 "XOMA's stock price took a tumble earlier in the week, but has rebounded well. We anticipate financial results from the company by the end of next week. It is not unusual for XOMA to take such an opportunity to disseminate other news as well. We believe that they are in the process of shutting down the meningococcemia trial, though we do not expect data until the 90-day follow-up period is complete. Before then, we should have a deal for I-PREX. XOMA is a buy under $4."